Yeah I don't think our $10's and $15's are going to be called away next month!
It will be interesting to see if KM has a plan to deal with formulary changes that other posters have warned about for 2023, or if the company is blindsided again without giving thought to an AG or more exclusive deals to lock market share.
Denner has been totally silent since his statement about the board, so I do wonder what his plan is or if he's just shorting to get his money back and then will bail. My hope is he forces his way to a seat at the table.
My avg is $3.78 so it would be nice to exit north of $5 a share at some point, and if I can finagle $6-8 I'll be ecstatic. I know others here are dead set against anything lower than $20 but that seems impossible to me.
News 
Market Data 
Discover 
